Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact
Dmitriy V. Semenov, Natalia S. Vasileva, Maya A. Dymova, Sergey V. Mishinov, Yulya I. Savinovskaya, Alisa B. Ageenko, Anton S. Dome, Nikita D. Zinchenko, Grigory A. Stepanov, Galina V. Kochneva, Vladimir A. Richter, Elena V. Kuligina · 2023
Read Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact by Dmitriy V. Semenov, Natalia S. Vasileva, Maya A. Dymova, Sergey V. Mishinov, Yulya I. Savinovskaya, Alisa B. Ageenko, Anton S. Dome, Nikita D. Zinchenko, Grigory A. Stepanov, Galina V. Kochneva, Vladimir A. Richter, Elena V. Kuligina (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10670333.txt.
Description
Oncolytic virotherapy is a rapidly evolving approach that aims to selectively kill cancer cells. We designed a promising recombinant vaccinia virus, VV-GMCSF-Lact, for the treatment of solid tumors, including glioma. We assessed how VV-GMCSF-Lact affects human cells using immortalized and patient-derived glioma cultures and a non-malignant brain cell culture.
Catalog record
| CREATOR | Dmitriy V. Semenov, Natalia S. Vasileva, Maya A. Dymova, Sergey V. Mishinov, Yulya I. Savinovskaya, Alisa B. Ageenko, Anton S. Dome, Nikita D. Zinchenko, Grigory A. Stepanov, Galina V. Kochneva, Vladimir A. Richter, Elena V. Kuligina |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |